Suzhou Medsys Tech Co Ltd

SHG:603990 China Health Information Services
Market Cap
$624.90 Million
CN¥4.59 Billion CNY
Market Cap Rank
#10498 Global
#2340 in China
Share Price
CN¥14.97
Change (1 day)
-0.47%
52-Week Range
CN¥11.02 - CN¥17.71
All Time High
CN¥4534.27
Categories
Companies in China Health Information Services Technology
About

Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive… Read more

Suzhou Medsys Tech Co Ltd (603990) - Net Assets

Latest net assets as of September 2025: CN¥843.80 Million CNY

Based on the latest financial reports, Suzhou Medsys Tech Co Ltd (603990) has net assets worth CN¥843.80 Million CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.25 Billion) and total liabilities (CN¥404.57 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥843.80 Million
% of Total Assets 67.59%
Annual Growth Rate 33.44%
5-Year Change -35.17%
10-Year Change 331.21%
Growth Volatility 88.13

Suzhou Medsys Tech Co Ltd - Net Assets Trend (2011–2024)

This chart illustrates how Suzhou Medsys Tech Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Suzhou Medsys Tech Co Ltd (2011–2024)

The table below shows the annual net assets of Suzhou Medsys Tech Co Ltd from 2011 to 2024.

Year Net Assets Change
2024-12-31 CN¥804.79 Million -26.81%
2023-12-31 CN¥1.10 Billion -19.13%
2022-12-31 CN¥1.36 Billion +24.00%
2021-12-31 CN¥1.10 Billion -11.68%
2020-12-31 CN¥1.24 Billion +144.77%
2019-12-31 CN¥507.18 Million +7.19%
2018-12-31 CN¥473.16 Million +9.08%
2017-12-31 CN¥433.79 Million +9.83%
2016-12-31 CN¥394.97 Million +111.63%
2015-12-31 CN¥186.63 Million +26.38%
2014-12-31 CN¥147.68 Million +36.19%
2013-12-31 CN¥108.43 Million +40.19%
2012-12-31 CN¥77.35 Million +308.97%
2011-12-31 CN¥18.91 Million --

Equity Component Analysis

This analysis shows how different components contribute to Suzhou Medsys Tech Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 23503790035.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock CN¥306.28 Million 38.30%
Other Comprehensive Income CN¥43.07 Million 5.39%
Other Components CN¥689.11 Million 86.18%
Total Equity CN¥799.63 Million 100.00%

Suzhou Medsys Tech Co Ltd Competitors by Market Cap

The table below lists competitors of Suzhou Medsys Tech Co Ltd ranked by their market capitalization.

Company Market Cap
Suzhou Xianglou New Material Co. Ltd.
SHE:301160
 		$479.22 Million
Saurer Intelligent Technology Co Ltd Class A
SHG:600545
 		$479.34 Million
Ningbo Exciton Technology Co Ltd
SHE:300566
 		$479.44 Million
Ceconomy AG
PINK:MTAGF
 		$479.45 Million
Kumho Tire
KO:073240
 		$479.16 Million
THE DUCKHORN P. DL -001
F:8B3
 		$479.11 Million
Compagnie Plastic Omnium SA
PINK:PASTF
 		$478.67 Million
Ennis Inc
NYSE:EBF
 		$478.58 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Suzhou Medsys Tech Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,096,302,645 to 799,632,758, a change of -296,669,887 (-27.1%).
  • Net loss of 279,474,697 reduced equity.
  • Dividend payments of 26,327,831 reduced retained earnings.
  • Share repurchases of 30,000,125 reduced equity.
  • Other comprehensive income increased equity by 45,178,388.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥-279.47 Million -34.95%
Dividends Paid CN¥26.33 Million -3.29%
Share Repurchases CN¥30.00 Million -3.75%
Other Comprehensive Income CN¥45.18 Million +5.65%
Other Changes CN¥-6.05 Million -0.76%
Total Change CN¥- -27.06%

Book Value vs Market Value Analysis

This analysis compares Suzhou Medsys Tech Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 5.69x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 130.97x to 5.69x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2011-12-31 CN¥0.11 CN¥14.97 x
2012-12-31 CN¥0.41 CN¥14.97 x
2013-12-31 CN¥0.59 CN¥14.97 x
2014-12-31 CN¥0.80 CN¥14.97 x
2015-12-31 CN¥1.01 CN¥14.97 x
2016-12-31 CN¥2.13 CN¥14.97 x
2017-12-31 CN¥2.30 CN¥14.97 x
2018-12-31 CN¥2.47 CN¥14.97 x
2019-12-31 CN¥2.62 CN¥14.97 x
2020-12-31 CN¥6.39 CN¥14.97 x
2021-12-31 CN¥5.22 CN¥14.97 x
2022-12-31 CN¥6.46 CN¥14.97 x
2023-12-31 CN¥3.58 CN¥14.97 x
2024-12-31 CN¥2.63 CN¥14.97 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Suzhou Medsys Tech Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -34.95%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -60.22%
  • • Asset Turnover: 0.15x
  • • Equity Multiplier: 3.96x
  • Recent ROE (-34.95%) is below the historical average (6.91%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2011 8.51% 2.59% 0.73x 4.53x CN¥-280.87K
2012 18.10% 13.82% 0.72x 1.83x CN¥6.27 Million
2013 28.67% 21.77% 0.73x 1.80x CN¥20.24 Million
2014 26.58% 21.75% 0.65x 1.89x CN¥24.48 Million
2015 20.87% 19.30% 0.46x 2.33x CN¥20.29 Million
2016 11.45% 18.79% 0.35x 1.75x CN¥5.71 Million
2017 11.78% 19.02% 0.43x 1.44x CN¥7.73 Million
2018 11.75% 19.52% 0.40x 1.52x CN¥8.24 Million
2019 9.40% 14.08% 0.44x 1.52x CN¥-2.99 Million
2020 2.89% 11.50% 0.20x 1.24x CN¥-87.21 Million
2021 3.83% 11.86% 0.27x 1.20x CN¥-67.52 Million
2022 2.47% 10.99% 0.19x 1.20x CN¥-102.04 Million
2023 -24.58% -43.59% 0.16x 3.57x CN¥-379.05 Million
2024 -34.95% -60.22% 0.15x 3.96x CN¥-359.44 Million

Industry Comparison

This section compares Suzhou Medsys Tech Co Ltd's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $996,002,714
  • Average return on equity (ROE) among peers: 10.70%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Suzhou Medsys Tech Co Ltd (603990) CN¥843.80 Million 8.51% 0.48x $479.20 Million
Vanfund Urban Investment & Development Co Ltd (000638) $221.59 Million 17.07% 2.05x $44.07 Million
Shanghai Kingstar Winning Software (300253) $2.41 Billion 21.55% 0.39x $2.11 Billion
Longmaster Information Tech (300288) $1.27 Billion 7.65% 0.20x $390.69 Million
B-Soft Co Ltd (300451) $344.85 Million 13.80% 0.44x $883.57 Million
Heren Health Co Ltd (300550) $630.00 Million 6.55% 0.51x $257.07 Million
Yarward Electronics Shandong Co. Ltd. A (301337) $1.10 Billion -2.40% 0.11x $152.94 Million